يعرض 1 - 10 نتائج من 169 نتيجة بحث عن '"Hudgens, S."', وقت الاستعلام: 1.45s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: College of Public Health, University of Arizona

    المصدر: Journal of Patient-Reported Outcomes

    مصطلحات موضوعية: Bring your own device, BYOD, COPD, Patient-reported outcome, PRO

    العلاقة: Hudgens, S., Newton, L., Eremenco, S. et al. Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings. J Patient Rep Outcomes 6, 119 (2022). https://doi.org/10.1186/s41687-022-00521-3Test; http://hdl.handle.net/10150/670432Test; Journal of Patient-Reported Outcomes

  5. 5
    دورية أكاديمية

    المساهمون: College of Public Health, University of Arizona

    المصدر: Journal of Patient-Reported Outcomes

    العلاقة: Newton, L., Knight-West, O., Eremenco, S., Hudgens, S., Crescioni, M., Symonds, T., Reasner, D. S., Byrom, B., O’Donohoe, P., Vallow, S., the Patient-Reported Outcome (PRO) Consortium, & Electronic Clinical Outcome Assessment (eCOA) Consortium. (2022). Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: Qualitative interview findings. Journal of Patient-Reported Outcomes, 6(1).; http://hdl.handle.net/10150/666032Test; Journal of Patient-Reported Outcomes

  6. 6
    دورية أكاديمية
  7. 7
    مؤتمر

    المصدر: Cella , D , Bookman , M , Steffensen , K D , Coleman , R L , Dinh , M , Khandelwal , N , Benjamin , K , Kamalakar , R , Sullivan , D , Floden , L & Hudgens , S 2020 , ' Health-related quality of life (HRQoL) in patients (pts) with newly diagnosed stage III or IV ovarian cancer treated with veliparib (vel) plus chemotherapy followed by vel maintenance (maint) ' , Annals of Oncology , vol. 31 , no. Suppl. 4 , 809MO , pp. S612 . https://doi.org/10.1016/j.annonc.2020.08.948Test

  8. 8
    مؤتمر
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    العلاقة: Migden, M., Rischin, D., Sasane, M., Mastey, V., Pavlick, A., Schmults, C., Chen, Z., Guminski, A., Hauschild, A., Bury, D., Hudgens, S., Chang, A. L., Rabinowits, G., Ibrahim, S., Fury, M., Lowy, I., Li, S. & Chen, C. -I. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. [Abstract]. SKIN The Journal of Cutaneous Medicine, 5 (1), pp.s5-s5. https://doi.org/10.25251/skin.5.supp.5Test.; http://hdl.handle.net/11343/288777Test